DL-Buthionine-sulfoximine

INQUIRY Add to cart
For research use only. Not intended for any clinical use
CATAP5072264-B
CAS5072-26-4
Structure: 
MDL NumberMFCD00070309
Molecular Weight222.31
InChI KeyKJQFBVYMGADDTQ-UHFFFAOYSA-N
REAXYS Number2367136
Description≥99.0% (TLC)
Size250MG, 1G, 5G
Assay≥99.0% (TLC)
SolubilityH2O: 50 mg/mL, clear to almost clear, colorless
Storage Conditions2-8°C

1Augmentation of Cisplatin (DDP) Cytotoxicity in Vivo by DL-buthionine Sulfoximine (BSO) in DDP-sensitive And-Resistant Rat Ovarian Tumors and Its Relation to DNA Interstrand Cross Links

G Chen, W J Zeller

Anticancer Res. Nov-Dec 1991;11(6):2231-7.

PMID: 1776864

Read More

1Depletion of Brain Glutathione in Preweanling Mice by L-buthionine Sulfoximine

A Slivka, M B Spina, H I Calvin, G Cohen

J Neurochem. 1988 May;50(5):1391-3.

PMID: 3361302

Read More

1Hepatotoxicity of Eugenol in Mice Depleted of Glutathione by Treatment With DL-buthionine Sulfoximine

T Mizutani, K Satoh, H Nomura, K Nakanishi

Res Commun Chem Pathol Pharmacol. 1991 Feb;71(2):219-30.

PMID: 2047567

Read More

1p-Dichlorobenzene-induced Hepatotoxicity in Mice Depleted of Glutathione by Treatment With Buthionine Sulfoximine

T Mizutani, Y Nakahori, K Yamamoto

Toxicology. Nov-Dec 1994;94(1-3):57-67.

PMID: 7801330

Read More

1Simultaneous Inhibition of Renal Phospholipase A(2) and Glutathione Synthesis by Manoalide and DL-buthionine Sulfoximine Induces Acute Tubular Dysfunction in Rats

A Soejima, S Ishizuka, N Miyake, K Fukuoka, M Suzuki, Y Kamiya, T Nagasawa

Exp Nephrol. Mar-Apr 2000;8(2):84-90.

PMID: 10729747

Read More

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office


  • Tel:
    Email:

Follow us on

Copyright © 2021 Analytical Products / Alfa Chemistry. All Rights Reserved.